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 ABSTRACT 
One of the most critical structures in cellular biology is the plasma 
membrane, due to its ability to respond to environmental stresses. 
Saccharomyces cerevisiae is a model, single-celled eukaryote that has 
been used to investigate many aspects of cell biology.  A recent genetic 
screen in yeast for plasma membrane homeostatic proteins identified 
three related proteins of unknown molecular function that participate in 
these processes.  These proteins, termed PDR19, PDR20, and PDR21 for 
Pleiotropic Drug Resistance, are each approximately one hundred amino 
acids in size and share a small conserved domain, namely the core 
sequence KITRYDL.  In the case of PDR21, the core sequence is 
VITRHDL.  The coding sequences for this set of proteins are found in the 
ORFs YGR035c, YLR346c and YPR145w-a, respectively.  A triple 
mutation of these genes led to an observed decrease in membrane 
homeostasis, when cells were treated with the membrane- disrupting 
compound digitonin, natural products that disturb membranes and in the 
presence of the clinical antifungal drug amphotericin B.  The observed 
phenotype suggests this set of novel proteins functionally regulate 
membranes in response to membrane-altering conditions, as an observed 
fifty-fold increase in membrane sensitivity of the triple mutant was 
observed.  In order to help determine the molecular function(s) of the PDR 
proteins, a GAL4 two-hybrid system is being used to screen for proteins 
that may associate with the PDR 19/20/21 family proteins and help 
 mediate their cellular functions.  That this system can be used has been 
confirmed through negative autoactivation tests involving a Gal4DBD-PDR 
fusion construct and done in a modified Y187/Y190 mating strain carrying 
the pACT II activation domain plasmid containing the ADGal4.  Plasmid 
sequencing of the Gal4DBD-PDR fusion proteins is in process to help 
confirm proper cloning of the bait proteins in addition to library screening.  
In addition to this work, bioinformatic characterization of genes involved in 
TTG cellular responses was conducted.  In a previous screen in the 
Erdman lab, 4,851 deletion strains were screened, of which 991 strains 
demonstrated a degree of sensitivity or resistance to TTGs.  In an attempt 
to further understand and classify these results, a bioinformatics tool was 
used to reveal underlying modes of genetic control governing the range of 
observed phenotypic sensitivities. 
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INTRODUCTION 
 
Perhaps one of the most crucial structures in cellular biology is the 
plasma membrane, because of its ability to respond to environmental 
stresses.  This is particularly the case with Saccharomyces cerevisiae, as 
they are single-celled eukaryotes that naturally remain in contact with the 
surrounding environment.  In order to regulate, and often times resist, 
environmental challenges such as osmotic pressure and chemical uptake, 
many cellular organisms adapt specialized plasma membranes, as is the 
case with S. cerevisiae.  The plasma membrane classically consists of a 
lipid bilayer membrane with distinct regions of hydrophillicity and 
hydrophobicity.  In addition to the presence of phospholipids, several other 
components, such as sterols, provide structural support and fluidity to a 
membrane bilayer.  Moreover, several gene products regulate ion and 
molecular channels in yeast membranes, as well as signal transduction 
associated with changes in permeability.  These components of the 
plasma membrane rarely act alone, often inducing multiple pathways.  The 
specific mechanisms of plasma membrane structure, fluidity, and channel 
regulation are of interest, for most biological systems have evolutionarily 
adopted the plasma membrane with little variation.  S. cerevisiae is an 
ideal experimental model system used in studying such underlying 
membrane mechanisms, due to its ease of genetic manipulation and 
analysis of phenotypic expression.  Understanding the mechanisms and 
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genetic components regulating membrane permeability and homeostasis 
will lead to a greater understanding in related biological systems. 
 
PLASMA MEMBRANE STRUCTURE 
The outermost layer of the cellular envelope in yeast is the cell wall.  
Essentially, this structure provides support and rigidity to the entire cell.  
Beneath the cell wall is the plasma membrane, which is responsible for 
providing a semi-permeable barrier for hydrophobic molecules greater 
than 600 Da[7].  The plasma membrane is composed of several different 
types of lipids, which possess different chemical and physical properties.  
This finding suggests a possible mechanism by which proteins within the 
membrane associate with distinct lipids[7].  One of the largest classes of 
lipids present in the membrane by percentage is the sphingolipids.  They 
may contribute as much as thirty percent of the total phospholipid content 
present in the plasma membrane[7].  The fatty acid chains present in the 
plasma membrane of S. cerevisiae largely include oleic acid (18:1) and 
palmitoleic acid (16:1) [7].  Essentially the packing level of these fatty acyl 
chains is what contributes to the overall fluidity of the plasma membrane.  
Tight packing of the fatty acyl chains results from increases in acyl chain 
length and consequently favors a membrane that is relatively more rigid, 
disallowing extensive lateral movement or permeation by hydrophobic 
solutes.  Equally important for the physical attraction of proteins, the head 
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groups present on the lipids influence membrane proteins, as well as the 
overall electrical potential of the membrane.       
While the membrane largely consists of a phospholipid bilayer, 
several integral proteins and sterol molecules play a key role in 
transporting solute molecules across the membrane.  Through vesicular 
transport, proteins are produced on rough endoplasmic reticulum and 
travel to the plasma membrane.  Transport vesicles bud off of the ER and 
fuse with the Golgi apparatus, initiated by a Ras-type GTP binding 
protein[7].  Through a GDP-GTP exchange protein the SAR1 protein 
becomes active, thereby initiating vesicular budding from the ER.  The 
GTP is consequently hydrolyzed upon completion of the formation of the 
vesicle[7].  Like most cellular processes, vesicular trafficking and 
membrane construction is the result of several interacting genetic 
pathways and gene products.  For instance, a single mutation in the GTP-
binding protein, Ypt1p, results in the consequential buildup of membranes 
within the cell[7].  In mammalian cells, the vesicular fusion process is 
similar, but involves three complexes known as SNAPs, v-SNARE, and 
the target fusion membrane, t-SNARE[7]. 
Several key proteins remain in contact with the plasma membrane.  
These proteins allow for ATP binding, diffusion, and other types of 
transport.  One of the larger families of proteins present in the membrane 
is the ABC transporter proteins.  Such proteins contain a conserved ATP-
binding cassette domain that allows these protein transporters on the 
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membrane to bind with ATP[7].  The protein composition of a plasma 
membrane, along with phospholipid and sterol content, greatly determines 
the degree of permeability allowed by the membrane.  In the most simple 
of cases, small solutes passively diffuse across the membrane without an 
expenditure of ATP.  Not surprisingly, most small solutes are more 
hydrophilic in chemical composition than hydrophobic.  A more specialized 
method of passive diffusion involves the use of channels that span the 
width of the bilayer.  Like most eukaryotes, yeast membranes include a 
potassium, K+, channel that closely regulates potassium efflux.  The next 
prevalent method of solute transport in yeast cells involves the active 
establishment of an electrochemical gradient, known as secondary 
transport.  The proteins involved in secondary transport are thereby 
responsible for establishing and maintaining a homeostatic gradient at all 
times.  In uniport secondary transport, the gradient is created by the 
passing solute and only transports one type of solute.  In yeast cells, this 
is often observed with monosaccharide transport.  In a symport system, 
the carrier protein co-transports two molecules in the same direction.  Ion 
secondary transport often occurs concurrently with the influx of sodium 
ions across the membrane.  Likewise, symport proteins regulate the 
transport of larger disaccharide molecules.  Lastly, in antiport transport, 
two solutes are simultaneously transported in opposite directions.  
Typically, this maintains the electrochemical potential within and outside of 
the cell.  A classic example of this particular type of transport is found in 
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most eukaryotic cells, in the form of an evolutionarily conserved sodium-
proton pump.  With the influx of sodium cations, there is an efflux of 
protons[7].  Understanding these modes of protein-mediated transport 
provides critical insight in studying membrane homeostasis. 
In almost all plasma membranes, the sterols play an integral role in 
membrane homeostasis and overall permeability.  Geometrically, sterols 
interrupt lipid interactions and layering within the membrane, thereby 
contributing both a degree of asymmetry and plausibly influencing integral 
protein activity[7].  In yeast, the ergosterol biosynthesis pathway largely 
directs sterol integration in the plasma membrane.  Ergosterol is 
analogous to the mammalian sterol, cholesterol.  Like most sterols, 
ergosterol is formed in the ER, and is synthesized from melvonic acid[7].  
This sterol is of particular interest since many naturally occurring 
environmental toxins complex with ergosterol, consequently disrupting the 
plasma membrane bilayer.  Interestingly, the gene products found within 
the ergosterol biosynthesis pathway are currently targets of interest in 
antifungal research.  Perhaps one of the most effective approaches in 
antifungal technology seeks to deplete the plasma membrane of its 
structural integrity and selective permeability.  Sterol binding by a natural 
or clinical drug, currently azole-based, may cause disruption of the plasma 
membrane.  Understanding the underlying genetic mechanisms of 
membrane homeostasis thus proves not only to be of genetic value, but, 
6 
perhaps more importantly, holds great clinical value in developing more 
effective antifungals.   
 
THE YEAST PDR NETWORK 
 
 My research project attempts to understand some of the underlying 
genetic mechanisms of plasma membrane resistance to naturally 
occurring antifungal compounds.  Perhaps one of the largest genetic 
contributors to observed phenotypic membrane resistance, in yeast, is the 
pleiotropic drug resistance gene network.  The PDR network contains a 
family of genes that participate in cellular activities, such as tolerance to 
membrane disturbing compounds and functioning in membrane 
transport[1].  Interestingly, several transcription regulators control the 
expression of genes functioning as membrane efflux pumps.  Such pumps 
have been shown to provide a mechanism of drug resistance.  Consider 
the transcriptional regulators PDR1, PDR3, PDR7, and PDR9.  Together, 
they control the gene expression of PDR5, whose encoded protein 
belongs to the ABC protein family and functions as a drug efflux pump[1].  
PDR1 and homolog, PDR3, regulate YOR1, SNQ2, and STE6.  Snq2p is 
analogous to the Pdr5p efflux pump and most likely functions in the 
cytosol.  Together, these proteins are responsible for observed resistance 
to various toxic compounds such as cycloheximide, triterpene glycosides 
(TTGs), and antimycin[7].  Not surprisingly, many PDR proteins are 
capable of transporting compounds through their ATPase activities.  
Additionally, the YAP regulatory stress response network contributes to 
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genetically controlled drug resistance[7].  It is believed that both the PDR 
and YAP networks function closely together to establish drug resistance. 
 Mechanistically, many antifungal drugs target the electron transport 
chain of the mitochondria, consequently disrupting ATP production and 
thereby eliminating membrane homeostatic processes.  Interestingly, 
though, in cases of phenotypic resistance to antifungals, signals from 
distressed mitochondria activate the PDR network.  Specifically, PDR1 
and PDR3 transcription factors undergo substitution mutations and results 
in an upregulation of PDR5[3], which consequently leads to an 
overexpression of membrane efflux pumps.  Moreover, both the loss of 
mitochondrial genes and the inner mitochondrial membrane protein, 
Oxa1p, results in the upregulation of PDR3[1].  Furthering these findings, in 
2000 it was observed that phenotypic resistance to the clinical antifungal, 
mucidin, was the result of a mutation in the PDR3 gene[4].  When 
compared to wildtype strains, deletion strains for the PDR1 and PDR3 
genes demonstrated the highest degree of drug sensitivity[4], suggesting 
these homologs are critical in pleiotropic drug resistance.  Furthermore, 
when a wildtype strain was grown in the presence of mucidin, there was 
almost a three-fold increase in the concentration of the Pdr5p efflux pump 
protein when compared to control cells[4].  
In general, it is believed that the PDR network is responsible for 
both efflux pumps and lipid membrane trafficking specific to drug 
resistance.  When considering the effects of both deleting the PDR1 and 
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PDR3 genes and the normal homeostatic processes involved with the 
plasma membrane, it becomes apparent that disturbing either the efflux 
pumps or ATP binding cassette proteins will lead to phenotypically 
observed sensitivity.  Moreover, given that the PDR network and related 
genetic pathways are numerous, a disturbance in any one particular target 
gene transcript could disturb drug resistance.  Moreover, it is likely that 
some of the current uncharacterized targets of the PDR network 
specifically contribute to either the efflux pump, or are involved in lipid 
membrane trafficking and/or cytosolic membrane ATP activity.      
 
 
IDENTIFYING THREE PDR PROTEINS of 
UNKNOWN MOLECULAR FUNCTION 
 
 
 In an attempt to further understand the underlying genetic 
mechanisms of pleiotropic drug resistance, a deletion screen in the 
Erdman lab (Syracuse University) attempted to understand phenotypic 
resistance to glycosides of triterpene C30 compounds.  These compounds 
are saponins that occur widely in plants as defense mechanisms.  
Amongst these naturally occurring defense compounds are chaconine, 
glycyrrhizic acid, gummosogenin, machaeric acid, and machaerinic acid.  
These compounds disturb plasma membranes in a variety of ways, 
including association with ergosterol molecules within the bilayer.  
Analogous to nystatin, the plasma membrane ATPase and chitin synthase 
activity are often pathway antifungal targets in sterol-rich domains.  
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Interestingly, it has been suggested that sterol-rich regions contain chitin 
synthases, while sterol-poor domains contain ATPases[7].  In either case, it 
becomes evident that drugs complexing with sterol bilayer molecules 
disturb normal membrane homeostatic processes. 
 A high copy suppression screen was carried out in an attempt to 
identify and isolate gene interactions with SIP3, whose protein resides in 
the plasma membrane.  SIP3 is known to positively associate with SNF1, 
a protein kinase involved with both nuclear histone phosphorylation and 
glucose repression states[2].  The SIP3 gene ontology (GO) molecular 
function classifies the gene for its involvement in transcription cofactor 
activity and is specifically responsible for the positive regulation of 
transcription from the RNA polymerase II promoter[2].  A high copy 
suppression screen involves the overexpression of candidate genes, and 
in this case positively identifies genes that influence resistance to TTG.  In 
this particular screen, the SIP3 strain exhibits super sensitivity to TTG.  In 
an experiment conducted by Gary Franke of the Erdman lab, 5,200 
transformant colonies and high copy plasmids were screened by 
transforming a yeast 2µ library into a SIP3 strain.  Of the 5,200 
transformant colonies screened for TTG sensitivity, 31 high-copy 
suppressors were isolated.  17 of these were retested and shown to cause 
TTG resistance.  Of these 17, a total of 11 unique high-copy suppressors 
were isolated.  With an average of 2-3 genes per insertion, and a yeast 
genome spanning approximately 6,000 genes, an estimated 11,700 
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genes, or nearly 2x the genome, were screened for TTG resistance(ttgR) 
phenotypes.   
 Of the candidate high-copy suppressors of the sip3∆strain, three 
genes of unknown molecular function were identified with coding 
sequences found in the following ORF’s:  YGR035c and YPR145c-a.  
Among other suppressor genes identified, PDR16 and LAG1 were 
isolated, both regulated by the PDR network.  Of the total candidate 
suppressor genes, most fell under three general molecular functions, 
namely  pleiotropic drug resistance, vesicular trafficking, and stress 
response.  A further investigation and understanding of the PDR network 
suggests that YGR035c and YLR346c are direct target genes of unknown 
molecular function regulated by PDR8, YRR1, and/or YRM1.  It is likely 
that TTG resistance may be caused by an overproduction of pleiotropic 
drug resistance proteins.  For the most part, PDR1/3, YRR1, and YAP1 all 
contribute to drug resistance.  Most of the PDR genes encode either ABC 
transporters, MFS permeases, or are involved in membrane metabolism.  
YGR035c, YLR346c, and YPR145c-a are regulated by the PDR network 
due to their observed phenotypic behaviors in response to membrane 
disturbing compounds.  YGR035c, YLR346c, and YPR145c-a are 
members of a small multigene family, sharing conserved KITRYDL and 
VITRHDL domains respectively.  A triple mutation of these genes led to an 
observed decrease in membrane homeostasis, when cells were treated 
with the membrane disrupting detergents digitonin, ketoconazole, and 
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TTG.  The same trends were observed when cells were exposed to the 
drugs cycloheximide, 4-NQ, SDS, and in the presence of the clinical 
antifungal drug amphotericin B.  The observed phenotype suggests that 
this set of novel proteins regulates membranes in response to membrane-
altering conditions, as an observed fifty-fold increase in membrane 
sensitivity of the triple mutant was observed for membrane acting 
compounds.  For their observed phenotypes and apparent roles in the 
pleiotropic drug resistance network, the YGR035c, YLR346c, and 
YPR145c-a genes were respectively termed PDR19, PDR20, and PDR21.  
In order to help determine the molecular function(s) of these PDR 
proteins, a GAL4 two-hybrid system is being used to screen for proteins 
that may associate with the PDR 19/20/21 family proteins and help 
mediate their cellular functions.  
 
THE YEAST TWO-HYBRID SYSTEM 
 
In order to determine the functions and molecular activities of the 
PDR 19 and 20 proteins, the yeast two-hybrid system is being used to 
investigate their possible relationships with other proteins involved in 
membrane homeostasis.  This technique allows for the identification of 
interacting proteins, by which a positive interaction signifies a similar 
cellular function and residence in a common protein complex.  Aside from 
sequencing a protein of unknown molecular function, it is often equally 
important to identify interactions with other proteins as a next step in trying 
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to uncover its function(s).  While it is largely believed that the suspect PDR 
proteins are involved in pleiotropic drug resistance, the yeast two-hybrid 
system will help identify interactions with other proteins. 
  In almost every process that occurs in the cell, there is an 
interaction between at least two, and often several, proteins.  Protein 
interactions vary widely and occur in various processes such as 
transcription, translation, vesicular trafficking, membrane homeostasis, 
and cellular signaling.  Protein-protein interactions play a pivotal role in 
normal cellular growth and homeostasis.  In the case of protein 
modifications, for example, there is necessarily a protein-protein 
interaction based on both chemical and physical attractions.  Protein 
kinases, glycosyl transferases, and phosphatases interact with their 
specific protein counterparts and allow for the transfer of a functional 
group from a specific amino acid[6].  Several genetic diseases are often 
manifested through aberrant protein-protein interactions, such as sickle 
cell anemia.  In the case of the pleiotropic drug resistance, the function of 
the PDR network is dependent upon gene products interacting with 
specific membrane proteins to elicit membrane homeostasis. 
The yeast two-hybrid system involves the use of in vivo DNA 
transcriptional machinery.  In particular, the system allows for the 
characterization of a protein of unknown molecular function based on an 
observed control protein interaction.  The GAL4 gene and associated 
transcriptional machinery is what ultimately allows for the success of the 
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two-hybrid system.  This constructed system makes use of two key 
concepts in gene transcription, regarding two DNA domains.  The DNA 
binding domain recruits factors that bind directly to the promoter cis 
region, while the activation domain actually initiates transcription.  In 
particular, transcription of GAL4 dependent promoters will not occur 
unless the DNA binding domain (DBD used in text to follow) is associated 
with a corresponding activation domain (AD used in text to follow).  
Interestingly, these two DNA domains do not need to be physically linked 
through covalent interactions[6], thus allowing for the construction of a two-
hybrid system.  Fields and Song first proposed and demonstrated this 
mechanism through their use of SNF1 and SNF4[6].  By creating fusion 
chimeras where SNF1 was fused to the DBD and SNF4 was fused to the 
AD, formation of a functional transcription factor was detected through 
phenotypic expression of the GAL4 reporter[6].  This experiment proves 
that two related proteins will associate through non-covalent interactions.  
By fusing a “bait”/suspect protein to the DBD and a known prey 
protein/library to the AD, successful association leads to reporter gene 
expression through the transcription of the reporter GAL4 gene.  In the 
event that the two proteins do not bind to one another, an interaction will 
not occur.  Thus the AD will not associate with the DBD, which will not 
result in transcriptional activity.     
As with any system, the two-hybrid system does have 
disadvantages.  Firstly, the construction of a two-hybrid system involves 
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the transformation of a protein of interest fused to the DBD into a yeast 
strain containing a reporter gene.  If the fusion protein causes transcription 
on its own, it is said to autoactivate the reporter.  In this particular case, 
the protein cannot be used as an effective “bait” in screening a library of 
AD fusion cDNA clones[6].  With any system that involves the use of 
chimeras, it is always possible for the native quaternary protein 
conformations to become compromised during genetic manipulation.  If 
the native conformations of the bait or prey protein are changed, it is quite 
likely that the proteins may not interact as they normally would do so in 
vivo.  Another apparent disadvantage in using the two-hybrid system is the 
obvious fact that protein-protein interaction occurs in yeast cells.  In 
studying proteins from other organisms by this system, it is essential that 
they be able to fold correctly in yeast[6], as failure to do so will undoubtedly 
disturb native covalent interactions.  Yet another disadvantage with the 
two-hybrid system is that the only measurable indication of interaction is 
the phenotypic expression of the reporter gene.  Although fairly unlikely, it 
is possible that a third protein could bridge the two fusion proteins, thereby 
initiating transcription of the reporter[6]. 
 Most of the aforementioned disadvantages are minor when 
considering the biological value of the system’s advantages.  Perhaps the 
most obvious advantage is the fact that the two-hybrid system employs 
the use of DNA transcriptional domains and associated machinery.  Unlike 
traditional biochemical approaches, protein-protein interaction in this 
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construct occurs in vivo.  Since detection does not occur in vitro or through 
bacterial expression, low affinity protein-protein interactions are noted 
more frequently by transcription of the reporter[6].  In other words, there is 
a significant degree of amplification in the form of the reporter, whereas 
some biochemical assays may not necessarily isolate these transient 
interactions.  Perhaps the greatest advantage of the system is that a 
known protein interactor can be used to functionally characterize an 
unknown protein in an in vivo environment.  This property makes the yeast 
two-hybrid system an effective tool in characterizing cascade signaling or 
even targets of cellular networks, such as the pleiotropic drug resistance 
network.  The speed and relative ease in creating fusion proteins makes 
this system an ideal tool in the characterization of protein interaction.            
 
 
EXPERIMENTAL APPROACH: Use of the GAL4 
two-hybrid system to attempt to identify proteins 
associating with PDR 19 and PDR20 
Perhaps one the most critical decisions in designing a two-hybrid 
system is the choice of the vector system.  The most frequently used DBD 
and AD containing vectors are based in the GAL4 system, as the reporter 
gene activity is easily evaluated.  However, in some cases other vectors 
are used, such as the LexA system[6].  Nonetheless, it is important to use 
a bait vector with certain features.  In this case, the pAS II vector was 
used.  The pAS II plasmid contains a hemaglutinin epitope tag, inserted in 
the GAL4 DBD reading frame[6], which allows for HA protein tagging and 
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visualization by immuno-blot.  Most plasmid vectors in yeast two-hybrid 
systems also include a selectable nutritional marker, as is the case with 
the TRP1 gene in pAS II.  This ultimately allows for selection upon 
transformation on synthetic complete media in the absence of tryptophan.  
The pAS II plasmid vector used in construction of the PDR two-hybrid 
system is of the following type:  DBDGAL4 HA epitope, TRP1.  In the case 
of the “prey”/library plasmid vector, pACT II was used, which contains the 
GAL4 activation domain.  As with pAS II, pACT II also allows for nutritional 
selection, but is selective on synthetic complete media minus leucine.  
Specifically, pACT II consists of the following selectable markers:  AD
 GAL4 
HA epitope, LEU2. 
 One obstacle that the GAL4 yeast two-hybrid system must 
circumvent is the inherent behavior of GAL4 and GAL80 in the presence 
or absence of galactose.  As is the case with all yeast genes, a functional 
TATA box is located upstream of the gene.  The promoter region of a 
functional gene typically includes the TATA box and its associated cis-
acting transcriptional elements.  One of the most prevalent cis-acting 
transcriptional elements present are the upstream activating sequences 
(UAS).  These sequences in yeast bind two regulatory proteins:  Gal4p 
and Gal80p.  These two regulatory proteins control galactose metabolism.  
In the presence of galactose, Gal4p binds to the GAL elements within its 
corresponding UAS[6].  However, in the absence of galactose, Gal80p 
binds to Gal4p, thereby blocking transcriptional activity.  Obviously, in 
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constructing a yeast two-hybrid system, it is necessary to avoid this 
natural interaction between the two GAL proteins.  To do so, the two-
hybrid system must contain deletions of the GAL4 and GAL80 genes, 
which consequently results in slower growth[6]. 
 In order to construct the PDR 19/20 two-hybrid system, the 
following yeast strains were used:  YSE859 Y190; MATa gal4 gal80 his3 
trp1-901 ade2-101 ura3-52 leu2-3, -112 URA3::Gal-lacZ, 
Lys2::GAL(UAS)-HIS3 and YSE32 Y187; MATα gal4 gal80 his3 trp1-901 
ura3-52 leu2-3,-112 URA3::GAL-LacZ. 
 The yeast strain Y190 was transformed with the plasmid pAS II and 
PDR19 and 20 clones:  YLR B-1, YLR A-4, YGR A-2, and YGR B-1.  This 
was done using a standard plasmid transformation into yeast protocol.  
2mL of Y190 yeast cells in YPD liquid media were grown overnight at 
30˚C in an incubator.  500µL of cells were spun down and the liquid media 
was aspirated.  100µL of one-step buffer (1mL stock:  200µL 2M LiAc, 
800µL 50% PEG, and 7.69 µL β-Mercaptoethanol) was added.  5 µL of 
salmon sperm DNA were added with 1 µL of the “bait” plasmid, pASII.  As 
mentioned, pAS II contains the DBDGAL4.  After heat shocking for 30 
minutes, the cells were plated on synthetic complete media minus 
tryptophan.  The pAS II carries TRP1 as a selectable nutritional marker.  
Transformants carrying the plasmid will therefore be able to grow on the 
SC-Trp media.   
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 The Y187 strain was successfully transformed with pACT II, 
containing the ADGAL4, using the transformation protocol.  Since pACT II 
contains a LEU2 nutritional selection marker, the cells were plated on SC-
leu media.  Rather than co-transforming the two fusion strains onto a SC-
leu-trp plate, a modified replica plating technique was used.  The Y190 
transformants were patched onto a SC-leu-trp plate and physically mated 
with the Y187 strain, containing the pACT II activation domain plasmid.  
Upon incubation at 30˚C, for two days, positive growth was noted on the 
SC-leu-trp plate signifying a successfully constructed two-hybrid system 
(See Appendix1).  Eventually, a library screen will be carried out, 
searching for proteins that interact with the novel PDR 19 and PDR 20 
proteins.  Isolating such protein interactions will increase understanding as 
to what the exact molecular functions of these novel proteins are and how 
they participate in membrane homeostasis. 
 
CONFIRMATION of NEGATIVE AUTOACTIVATION TESTS 
The constructed yeast two-hybrid system is largely based on the 
transcriptional activity of the reporter GAL4 gene.  Since the system 
involves the control clones and the “bait” pAS II DNA binding domain 
plasmid, it is important to make sure that transcription is in fact due to the 
interaction between two interacting proteins and not DBD fusion activation.  
The Y190 strain used in the early transformations contains a reporter gene 
used to assess autoactivation, namely the HIS3 gene.  Activation of the 
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reporter would be due to autoactivation by the DBD/ PDR19 and/or 20 
fusions, thereby initiating transcription of the reporter gene.   
 The presence of the reporter HIS3 gene allows for nutrional 
selection on SD media in the presence of varying concentrations of the 
HIS3 protein competitive inhibitor, 3-aminotriazole.  Following collection 
and cultivation of independent transformants for the bait plasmids, 
autoactivation was studied by observing growth on SD-His media.  
Theoretically, an increase in the concentration of the histidine enzyme 
should lead to an increase in the concentration of histidine even in the 
presence of the 3-aminotriazole competitor, hence growing on SD+40mM 
aminotriazole.  This of course reflects activation by the DBD-fusions, and 
is thereby indicative of autoactivation in the constructed GAL4DBD-PDR 
fusion proteins.   
 In order to assess for autoactivation in the PDR19/20 yeast two-
hybrid construct, growth relative to known interactors were compared.  For 
the positive growth control, the YSE1340 strain (Y190 carrying an Erdman 
lab constructed bait plasmid PXL1-DBD) plus OSE3-AD was patched on 
SD + 40mM aminotriazole and incubated for 24 hours.  This yielded 
positive growth on the media, as activation of the GAL-HIS3 promoter lead 
to an increase in the concentration of the His enzyme, thereby increasing 
the concentration of free histidine.  For the negative growth control, 
YSE1340 plus the pACT II carrying the empty AD was assessed.  After 24 
hours of incubation, no growth was observed.  In the mated Y187/859 
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(containing PDR/pACT II) no activation of the promoter was observed, and 
hence no observed growth.  Upon patching on SD+40mM aminotriazole, 
there was no observed growth for all Y187/859 strains containing the 
PDR19/20 baits and empty activation domain vector (See Appendix 1b).  
This indicates that these fusions can be used for future screens using the 
system.   
 Currently, plasmid sequencing of the GAL4DBD-PDR fusion 
proteins is in process to help confirm proper cloning of the bait proteins 
prior to library screening (See Appendix 2).    
 
FUNSPEC ANALYSIS of TTG RESISTANCE and SENSITIVITY AMONG 
NON-ESSENTIAL S.cerevisiae GENES 
 
  
In studying the composition of cell membranes, at least two 
unanswered questions can target the direction of research.  First, how do 
fungi cope with naturally occurring products present in their environments, 
which may be toxic to them through affecting their cell membranes?  Many 
such natural products are thought to exist in plants as defense 
mechanisms.  Secondly, how do eukaryotic cells in general maintain 
membrane homeostasis in the event of environmental challenges?  The 
yeast genome is comprised of roughly 6,000 genes.  Nearly 30% of yeast 
ORF’s encode membrane proteins, a statistic that should come at no 
surprise considering the number of different compartment membranes in 
eukaryotic cells.  Every compartment membrane has a genetically 
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controlled mechanism that maintains membrane homeostasis.  Currently, 
there are approximately 900 yeast ORF’s with unknown functions, some of 
which could function in membrane homeostasis.  This appears to be the 
case for the recently isolated family of proteins PDR 19/20/21. 
 One of our aims is to understand how eukaryotic cells maintain 
membrane homeostasis in the face of environmental challenges.  Of the 
many natural products fungi encounter, some glycosides of triterpenes are 
known to present a possible challenge to membrane integrity and overall 
homeostasis.  Triterpenes are natural C30 compounds, whose glycosides 
are saponins that occur in plants as a possible defense compound.  TTGs 
disturb membranes through such mechanisms as sterol binding, often 
rendering the membrane more permeable.  Studying membrane disturbing 
compounds and their associated effects on membrane disruption allows 
for further insight into both the pleiotropic drug resistance network and 
how vesicular trafficking proteins maintain membrane homeostasis.  
Interestingly, wild type yeast backgrounds differ in resistance to TTGs.  
For instance, the wild type W303 strain is sensitive, while BY4743 and its 
derivatives are not as sensitive.  In a previous screen in the Erdman lab, 
4,851 deletion strains of the BY4743 background were screened, of which 
991 strains demonstrated a degree of sensitivity or resistance to TTGs 
relative to the wild type strains.  Of the 991 strains, 110 were 
supersensitive, 276 were sensitive, 407 were moderately sensitive, and 53 
deletion strains were weakly sensitive.  A total of 131 resistant strains 
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were isolated.  Interestingly, it is estimated that 80% of the TTG 
phenotypes are linked to kanMX.  KanMX was systematically used to 
replace ORFs, in essence establishing an ORF knock-out collection.  The 
results from the deletion screen are of interest, for there must be an 
underlying mode of genetic control governing the range of observed 
phenotypic sensitivities.  In an attempt to further understand and classify 
these results, a bioinformatics tool, Funspec (T. Hughes Lab, U. Toronto) 
was used[2].  Funspec is a program that queries yeast databases with an 
input set of genes (in our case the genes whose deletion leads to TTG 
sensitivity or resistance), and compares their MIPS (Munich Information 
Center for Protein Sequences) and GO (Gene Ontology) classifications to 
those of all the genes present in the yeast genome.  Such classifications 
take into consideration the molecular function, cellular component, 
subcellular localization, and protein complexes.   
  
 
TTG RESISTANCE 
 
 In querying yeast databases with an input set of genes whose 
deletions confer resistance, there were several common MIPS and GO 
classifications that perhaps offer insight into drug resistance and cellular 
processes controlling membrane homeostasis.  Interestingly, the greatest 
possibility value (p) for GO biological processes showed that most genes 
are involved with the sterol biosynthetic process, phospholipid 
translocation, and steroid biosynthetic processes in general.  This finding 
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is consistent with the notion that TTG resistance employs alternative 
proteins of sterol biosynthetic pathways, and perhaps thereby physically 
resists alterations in the lipid bilayer.  Not surprisingly, one of the main 
targets of TTGs is in fact the bilayer integral sterol molecule.  Sterols, 
among other functions, are responsible for controlling the fluidity of the 
lipid bilayer.  TTG targeting of sterol molecules disturbs membranes 
through a variety of mechanisms, most notably TTG complexes to 
ergosterol.  The following ergosterol genes are involved with resistance:  
ERG2, ERG3, and ERG6, perhaps conveying resistance to TTGs (See 
Appendix 3a).   
 Additionally, several of the TTG resistant genes are involved with 
phospholipid translocation.  DRS2, DNF2, and LEM3 all function to 
maintain membrane homeostasis.  DNF2 and DRS2 are both 
aminophospholipid translocases or flippases that are involved in 
endocytosis, protein transport, and cell polarity.  Both are type 4 P-type 
ATPases.  KES1 and CYB5 are also involved with membrane 
homeostasis and TTG resistance.  KES1 is a member of the oxysterol 
binding protein family that regulates Golgi complex secretory functionality.  
Like the other proteins in its functional class, Kes1p functions on the 
cytosolic side of the plasma membrane.  In the case of CYB5, Cytochrome 
b5, it is involved in sterol biosynthetic pathways, and specifically donates 
electrons to support C5-6 desaturation[2].   
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 As previously mentioned during the discussion of the PDR network, 
plasma membrane resistance is often induced by signals produced from 
dysfunctional mitochondria.  Loss of the inner mitochondrial protein Oxa1p 
results in a generated signal that increases the concentration of PDR5, a 
membrane efflux pump of the ABC superfamily[3].  In other cases, 
substitution mutations within the PDR1 or PDR3 proteins result in 
observed pleiotropic drug resistance, by again increasing the 
concentration of the PDR5 efflux pump protein.  Not surprisingly, when 
looking at the bioinformatics of cellular respiration and mitochondrial 
function involved in TTG resistance, almost all genes encode proteins that 
are functionally involved in processes that occur within the inner 
membrane of the mitochondria.  IMP1, CYC3, and COR1 are three prime 
examples of this observation.  IMP1 is a gene whose protein functions in 
the catalytic subunit of the mitochondrial inner membrane peptidase 
complex[2].  In the case of COR1, the protein functionally resides in the 
subunit of the ubiquinol-cytochrome c reductase complex, and is again a 
component within the inner membrane electron transport chain[2]. 
 Aside from cellular functions involving membrane phospholipids, 
sterol biosynthesis, and mitochondrial functionality, TTG resistance also 
seems to be characterized by changes in cell polarity and cellular 
signaling.  Genes involved in these processes include membrane protein 
genes such as LEM3 and cdc42p-activated signal transducing kinases 
such as STE20.  When considering all of the genes above, it becomes 
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clear that TTG resistance is not controlled by any one particular gene, but 
rather is a collaborative genetic product of several networks.  Such 
networks include ergosterol biosynthesis, mitochondrial functionality, PDR, 
YAP, and cellular signaling.  Additionally, several novel genes of unknown 
function have been found as a result of both TTG screens and 
bioinformatic approaches.  Such genes include YPL191c, YBL089w, 
YFL006w, YBR255w, YKL023w, and YNR047w.  It is possible that one or 
more of these genes function in one of the key genetic pathways 
mentioned.  
TTG SENSITIVITY 
 Upon evaluating the TTG sensitive genes, an interesting trend 
develops.  Although many of the cellular functions fall under the same 
category, the individual genes involved differ from those expressed in TTG 
resistant phenotypes.  Consider TTG sensitive genes involved in 
membrane phospholipids and sterols.  Unlike genes involved in 
resistance, a different set of ergosterol genes are involved in sensitivity.  
Particularly, the following ergosterol genes are involved:  ERG4 and 
ERG5.  Additionally, OSH3 is involved with membrane sensitivity (See 
Appendix 3b).  Interestingly, TTG sensitivity employs the use of OSH3, an 
oxysterol-binding protein involved in sterol metabolism, whereas TTG 
resistance entails the expression of OSH4/KES1.  OSH4/KES1 is involved 
in the negative regulation of the Sec14p, which is a phosphatidylcholine 
transfer protein.  OSH4 de-regulates Golgi vesicular trafficking that is 
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regulated by the Sec14p [2], and overall perhaps influences lipid 
distribution within the membrane. 
 Interestingly, TTG sensitivity also returned genes involved in cell 
wall assembly and stress response proteins.  Such is the case with SFL1, 
which is an activator of stress response genes[2].  Likewise, GAS1 is a 
gene required for cell wall assembly, as its protein specifically functions as 
a glycophospholipid-anchored surface protein.  Perhaps one of the most 
interesting observations concerns the killer toxin resistance genes:  FYV4, 
FYV6, and FYV12.  These genes, when deleted, cause TTG sensitivity, 
even though the precise molecular functions of these proteins are 
currently unknown.  It appears, though, that these genes are activated in 
response to K1 killer toxin.  Perhaps the activation of these genes is in 
response to a disturbance that mimics TTG membrane disruption.  In fact, 
KI is a perforating protein that destroys sensitive yeast cells[2].  In this 
case, it appears that the FYV genes are not effective in resisting 
membrane disruptions created by TTGs, but are activated as a result of 
the yeast cell’s overall sensitivity.  In resistant strains it was noted that 
PDR genes and sterol biosynthetic pathways were activated. 
 Additionally, in TTG sensitivity, mitochondrial function and 
respiration cellular functions are not observed.  This offers further support 
that sensitive strains do not activate the PDR1/3 genes through 
mitochondrial signaling, which results in overexpression of the ABC type 
PDR5 efflux pump.  If the functional classes of genes enriched in the TTG 
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screen are compared between the resistant loci and sensitive loci, several 
differences are noted.  Generally, TTG resistant loci encode ribosomes, 
lipids, isoprenoids, and sterols.  TTG sensitivity-causing loci involves 
functional classes such as transport ATPases, lipids, sterols, and ion/pH 
homeostasis.  When considering these two groups of functional classes, a 
trend becomes apparent.  TTG resistance generally involves ribosomal 
machinery and translational events, suggesting that there is an active 
attempt by the cell to express gene products that operate to maintain 
membrane homeostasis.  Moreover, different ergosterol pathways are 
used to resist TTG membrane disturbances.  With TTG sensitivity, 
different functional classes are involved, in particular ATPases.  As 
previously mentioned, TTGs complex with sterols and perhaps disrupt 
ATPase activity.  Curiously, sensitivity maybe related to cellular attempts 
to replenish ATPase activity, while a degree of resistance entails a 
different sterol biosynthetic pathway to produce un-complexed sterols.  
While this has not been proven, there is strong supporting bioinformatic 
evidence, as will be discussed in the next section. 
 
ERGOSTEROL BIOSYNTHESIS in RESPONSE to TTG 
In analyzing the results of the two queries involving TTG resistance, 
some mechanisms through which membrane homeostasis may be 
disrupted become evident.  As illustrated in the results above, TTG can 
associate with ergosterol, possibly leading to an increase in ergosterol 
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concentration by the cell as a compensatory mechanism.  Interestingly, 
different components of the ergosterol biosynthetic pathway are involved 
in the resistant strains, which suggest possible resistance due to 
byproduct formation.  Inactivation of ERG3/6/2 and KES1 cause 
phenotypic TTG resistance, while ERG4/5 and the oxysterol binding 
protein OSH3 lead to sensitivity. 
 A closer investigation of the ergosterol biosynthetic pathway 
reveals that genes involved in TTG resistance may produce enol 
byproducts, which could lead to an increased production of sterols.  
Specifically, ERG 6 is capable of producing dienol, trienol, and tetranol 
byproducts.  ERG2 likewise produces enol, dienol, and trienol forms.  
Lastly, ERG3 produces byproduct sterols existing in both enol and dienol 
forms.   
 When considering these results, it becomes apparent that while 
TTG complexes with ergosterol, sensitive strains may only activate 
ERG5/4, which consequently increases the concentration of ergosta-
5,7,22-trienol (ergosterol).  The ergosterol molecules produced are 
identical to the integral ergosterol molecules within the bilayer, resulting in 
further complexing by TTGs.  In resistant strains, the ergosterols are not of 
the ergosta-5,7,22-trienol form, and exist in the enol byproduct forms 
previously mentioned.  Interestingly, in resistant strains the concentrations 
of these byproduct enol forms increase upon exposure to TTG, suggesting 
that these forms are perhaps incapable in complexing with TTG, thereby 
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leading to increased phenotypic resistance.  Sensitive strains cannot 
produce any other form of ergosterol, which perhaps leads to the 
observed sensitivity. 
 In a related observation, azole drug mediated fungal targeting 
currently seeks to target ERG11.  Azole targeting in yeast targets a 
cytochrome P450 which is a C14α-demethylase, encoded by ERG11.  
Targeting the gene product of ERG11, namely C14α-demethylase, confers 
sensitivity.  Resistance, however, can occur via an alternative pathway of 
a mutated ERG3 gene.  In this case, normal sterol production is altered 
during subjection to the antifungal drug, consequently developing a 
deficiency in a sterol desaturase, and the cell thereby resists membrane 
degradation.  Another focus involves further analysis of the ERG4 gene, 
one of the final genes in the pathway, responsible for the sterol C-24 
reductase.  Upon deletion of this specific gene, ergostan 5,7, 22, 24-
tetraen-3β-ol, a precursor to ergosterol, accumulates within the 
membrane, which might explain the observed drug hypersensitivity.   
 Interestingly, our investigation pertaining to the suppression 
screens used with TTG to analyze compensatory mechanisms in the 
absence of ergosterol produces similar drug resistance patterns as with 
previous antifungal tests.  This, once again, suggests that there is a broad 
cellular response to drugs that act as membrane disturbing compounds. 
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CONCLUDING REMARKS 
 The plasma membrane is one of the most critical structures in cells.  
Through regulation and homeostatic measures, the membrane resists 
environmental challenges, such as naturally occurring toxic compounds.  
In an attempt to further understand the underlying genetic mechanisms, 
recent genetic screens in yeast for plasma membrane homeostatic 
proteins identified three related proteins of unknown molecular function 
that participate in these processes.  These proteins, termed PDR19, 
PDR20, and PDR21 for Pleiotropic Drug Resistance, are each 
approximately one hundred amino acids in size and share a small 
conserved domain.  The coding genes for this set of proteins may be 
found in the ORFs YGR035c, YLR346c and YPR145w-a, respectively.  
Functionally, these proteins appear to be effectors of the PDR network, as 
a triple mutation of these genes led to an observed decrease in membrane 
homeostasis, when treated with the membrane disrupting reagents.  The 
observed phenotype suggests this set of novel proteins acts to functionally 
resist/regulate membranes in response to membrane-altering conditions.  
Further analyses suggest a functional role not only in chemical resistance, 
but perhaps also in membrane composition.  
 (i)  In order to determine the functions and molecular activities of 
the PDR proteins, the yeast two-hybrid system will be used to investigate 
their relationship with other related proteins involved in membrane 
homeostasis.  This technique allows for the identification of interacting 
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proteins/components, and is also a tool to manipulate native interactions.  
A yeast two-hybrid system containing the PDR19/20 proteins has 
successfully been constructed, although screening for interactors has not 
yet occurred.  That this system can be used has been confirmed through 
negative autoactivation tests involving a related protein from a modified 
Y187/Y190 mating strain and the pACT II activation domain plasmid 
containing the ADGal4.  Plasmid sequencing of the Gal4DBD-PDR fusion 
proteins is in process to help confirm proper cloning of the bait proteins in 
addition to library screening.   
 (ii)  One of the many aims in studying membrane homeostasis is to 
further understand resistance and sensitivity associated with exposure to 
naturally occurring toxic compounds.  Of the many natural products, fungal 
cells may encounter some glycosides of triterpenes are known to present 
challenges to membrane integrity and overall homeostasis.  In a screen 
for the effects of TTG membrane disruption, 4,851 yeast deletion strains 
were screened, of which 991 demonstrated a degree of sensitivity or 
resistance.  In attempt to categorize and further understand the genetic 
components involved with these phenotypes, a bioinformatic tool was 
employed.  Funspec analysis demonstrated that there are distinct genetic 
candidates and pathways involved in mediating resistance or sensitivity to 
membrane disturbing compounds.  Most notably, the ergosterol 
biosynthetic pathway and PDR networks were synonymous with 
phenotypic resistance.   
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 Understanding the homeostatic processes and resistance patterns 
involved with drug challenges holds significant clinical importance.  Fungal 
infections are especially devastating to pediatric patients and those with 
immunosuppressed systems, such as AIDS patients.  Through an 
understanding of the biosynthetic pathways essential for membrane 
homeostasis, it is quite possible that novel non-invasive treatments for 
fungal infections may be developed.  Such antifungal activities would 
target specific components and pathways essential for membrane stability.  
Identifying and isolating the novel proteins involved in these pathways is 
an important step in developing such treatments.  In addition, such studies 
also lead to a greater understanding of our own cells.  When we consider 
that one of the greatest challenges in drug design today is cellular uptake 
of compounds by the plasma membrane, even the smallest of discoveries 
may one day have a much more profound impact. Our findings regarding 
plasma membrane homeostasis mechanisms will contribute to a much 
larger collection of biomedical discoveries that are medically important to 
drug design and delivery mechanisms.         
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APPENDICES 
Appendix 1: 
a.) 
 
 
 
 
 
 
 
 
 
 
 
Generation of a modified Y187/Y190 mating strain and the pACT II 
activation domain plasmid containing the ADGal4.  Yeast strain Y190 was 
transformed with the “bait” plasmid pAS II and control clones:  YLR B-1, 
YLR A-4, YGR A-2, and YGR B-1 on synthetic complete (SC) media 
minus Trp.  Using a modified replica plating technique, the Y190 
transformants were successfully mated with Y187 strain, containing the 
pACT II activation domain plasmid, allowing growth on an SC-Trp-Leu 
plate.   
 
 
b.)    Evaluation of Autoactivation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Positive growth on SD + 40 mM  
aminotriazole [Y1340+p507   
(Pxl1p-Dse3 interaction)] 
No growth of all Y187/859 strains 
 containing the PDR19  
and PDR20 baits and an empty  
activation domain vector 
YGR A-2 
YGR B-1 
YLR B-1 
YLR A-4 
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Appendix 2: 
 
 
 
 
 
 
 
 
 
Gel electrophoresis showing 
plasmid DNA containing the 
GAL4DBD-PDR fusion proteins.  
Future plasmid sequencing will 
help to confirm proper cloning of 
the bait proteins. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
YLR B-1 pASII (1) 
YGR A-2 pASII (4,5) 
1 4 5 
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Appendix 3:  
a.) 
Key Funspec Analysis of TTG Resistant Genes 
            
 
P<0.005 k: number of genes from the input cluster in given category.f: number of genes 
total in given category. 
 
MIPS Functional Classification        
 
Category                     p-value      In Category from Cluster   k        f                                    
 
Ribosomal Proteins       5.91e-05    RPL19B RPS8A RPL23A RML2     15  246                                   
                                              RPL24B RPS24B RPS21B RPL14A 
                                                        RPL8B RPL6B MRPL39 RPS18B  
                RPS10B RPS7B RPP2A  
 
Tetracyclic/pentacyclic     0.004513            ERG3 ERG6 ERG2 KES1   4     36                                       
triterpenes metabolism  
 
GO Biological Process         
Sterol biosynthetic     0.0002188          ERG3 ERG6 ERG2 CYB5  KES 1        5     30 
process                          
 
Phospholipid      0.001286          DRS2 DNF2 LEM3           3    20     
translocation        
 
Steroid biosynthetic           0.001325       ERG3 ERG6 ERG2 KES1     4    26 
process           STE14 STE20                                              
 
GO Cellular Component         
Ribonucleoprotein      0.0001149         RPL19B RPS8A RPL23A    17 324 
complex        RML2 NOP16 RPL24B                                        
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b.)  
Key Funspec Analysis of TTG Sensitive Genes 
 
MIPS Functional Classification        
 
Category                                 p-value                   In Category from Cluster k     f 
 
Homeostasis of protons           0.0006376               PPA1 VMA5 VPH2 VMA6       5    47 
   ATP15                                                  
 
Tetracyclic/pentacyclic             0.001938                ERG4 OSH3 YEH2 ERG5  4    36                                                    
triterpenes metabolism 
 
GO Biological Process         
Double-strand break repair      0.001239                 RSC1 RAD27 FYV6 RAD50    4     32                                              
via nonhomologous end  
joining  
 
GO Cellular Component 
proton-transporting two-sector  0.0004013              PPA1 VMA5 VMA6 ATP15  4      24                                               
ATPase complex   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
